138 related articles for article (PubMed ID: 24956858)
21. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
22. Betulinic acid-mediated inhibitory effect on hepatitis B virus by suppression of manganese superoxide dismutase expression.
Yao D; Li H; Gou Y; Zhang H; Vlessidis AG; Zhou H; Evmiridis NP; Liu Z
FEBS J; 2009 May; 276(9):2599-614. PubMed ID: 19348625
[TBL] [Abstract][Full Text] [Related]
23. Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation.
Li H; Li J; Tang Y; Lin L; Xie Z; Zhou J; Zhang L; Zhang X; Zhao X; Chen Z; Zuo D
Virol J; 2017 Sep; 14(1):178. PubMed ID: 28915824
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
[TBL] [Abstract][Full Text] [Related]
25. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
[TBL] [Abstract][Full Text] [Related]
26. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
27. Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
Zhang M; Wu X; Lai F; Zhang X; Wu H; Min T
J Agric Food Chem; 2016 May; 64(20):4068-77. PubMed ID: 27144395
[TBL] [Abstract][Full Text] [Related]
28. Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients.
Lu YP; Guo T; Wang BJ; Dong JH; Zhu JF; Liu Z; Lu MJ; Yang DL
World J Gastroenterol; 2008 Jun; 14(22):3490-6. PubMed ID: 18567076
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
30. Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model.
Dai J; Chen EQ; Bai L; Gong DY; Zhou QL; Cheng X; Huang FJ; Tang H
Virol J; 2012 Nov; 9():280. PubMed ID: 23171829
[TBL] [Abstract][Full Text] [Related]
31. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
[TBL] [Abstract][Full Text] [Related]
32. Antiviral effect of hepatitis B virus S/C gene loci antisense locked nucleic acid on transgenic mice in vivo.
Deng YB; Qin HJ; Luo YH; Liang ZR; Zou JJ
Genet Mol Res; 2015 Aug; 14(3):10087-95. PubMed ID: 26345946
[TBL] [Abstract][Full Text] [Related]
33. Different antiviral effects of IFNα and IFNβ in an HBV mouse model.
Zhou Y; Li S; Tang Z; Xu C; Huang S; Wu J; Dittmer U; Dickow J; Sutter K; Lu M; Yang D; Song J
Immunobiology; 2017 Mar; 222(3):562-570. PubMed ID: 27839836
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses.
Cao L; Wu C; Shi H; Gong Z; Zhang E; Wang H; Zhao K; Liu S; Li S; Gao X; Wang Y; Pei R; Lu M; Chen X
J Virol; 2014 Aug; 88(15):8656-66. PubMed ID: 24850745
[TBL] [Abstract][Full Text] [Related]
35. [Antiviral effects of dual-target antisense rna: an experimental study with hepatitis B virus transgenic mice].
Zhao W; Chen H; Peng ZY; Li WG; Xi HL; Xu XY
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3486-90. PubMed ID: 16686065
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
Chen J; Wang Z; Zhou B; Wang Y; Hou J
Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
[TBL] [Abstract][Full Text] [Related]
38. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]